ASML CEO Christophe Fouquet says lithography stays central as chipmakers build more powerful artificial intelligence chips. • ASML Holding stock is showing weakness. Why is ASML stock retreating? Fouquet told Bloomberg on Friday that the company will focus on resolution, accuracy and…
Oracle Corp. (NYSE:ORCL) stock declined Friday as markets weighed execution risks around the company’s rapidly scaling AI and cloud capacity buildout. The pullback followed a Bloomberg report that said Oracle has shifted timelines for several OpenAI data centers to 2028…
Aardvark Therapeutics, Inc. (NASDAQ:AARD) is a clinical-stage biopharmaceutical company developing small-molecule therapeutics designed to suppress hunger for Prader-Willi Syndrome (PWS) and metabolic diseases. Lead compound, oral ARD-101, is in Phase 3 clinical development for hyperphagia associated with PWS, a rare…
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) stock is trading lower on Friday, with a session volume of 42.39 million compared to the average volume of 3.51 million as per data from Benzinga Pro. • Tenaya Therapeutics stock is feeling bearish pressure. What’s pressuring…
On Friday, the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion for Novo Nordisk A/S’ (NYSE:NVO) higher dose of Wegovy (semaglutide 7.2 mg). Novo Nordisk has also applied to the EMA for…
The U.S. Food and Drug Administration (FDA) is reportedly considering adding a boxed warning — the agency's highest-level safety alert — to Covid-19 vaccines, a move that has drawn immediate criticism from outside experts who say there is no evidence…
Eli Lilly and Co. (NYSE:LLY) on Friday shared updated results from the Phase 3 EMBER-3 study of Inluriyo (imlunestrant) for previously treated breast cancer patients. The trial included patients with estrogen receptor positive (ER+), human epidermal growth factor receptor 2–negative…
Arcus Biosciences, Inc. (NYSE:RCUS) on Friday announced the discontinuation of the Phase 3 STAR-221 study, being conducted in partnership with Gilead Sciences, Inc. (NASDAQ:GILD), due to futility. • Arcus Biosciences stock is among today’s weakest performers. Why is RCUS stock…
Tesla, Inc. (NASDAQ:TSLA) remains the undisputed “Robotaxi King” with its Cybercab, but two contenders battle for the rest of the autonomous market. In the race for second place, Rivian Automotive, Inc. (NASDAQ:RIVN) and Lucid Group, Inc. (NASDAQ:LCID) are selling two…
Relay Therapeutics, Inc. (NASDAQ:RLAY) on Friday shared a subset analysis of interim clinical data for zovegalisib (RLY-2608). Subset analyses showed broad activity in patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer, regardless of prior fulvestrant or other SERD exposure or ESR1…